DK0921806T3 - Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser - Google Patents

Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser

Info

Publication number
DK0921806T3
DK0921806T3 DK97934624T DK97934624T DK0921806T3 DK 0921806 T3 DK0921806 T3 DK 0921806T3 DK 97934624 T DK97934624 T DK 97934624T DK 97934624 T DK97934624 T DK 97934624T DK 0921806 T3 DK0921806 T3 DK 0921806T3
Authority
DK
Denmark
Prior art keywords
mannose
treatment
phosphate preparation
fibrous disorders
fibrous
Prior art date
Application number
DK97934624T
Other languages
Danish (da)
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK0921806T3 publication Critical patent/DK0921806T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DK97934624T 1996-08-12 1997-07-31 Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser DK0921806T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616896.8A GB9616896D0 (en) 1996-08-12 1996-08-12 Pharmaceutical compositions
PCT/GB1997/002076 WO1998006406A1 (en) 1996-08-12 1997-07-31 Mannose-6-phosphate composition and its use in treating fibrotic disorders

Publications (1)

Publication Number Publication Date
DK0921806T3 true DK0921806T3 (da) 2003-12-08

Family

ID=10798358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934624T DK0921806T3 (da) 1996-08-12 1997-07-31 Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser

Country Status (12)

Country Link
EP (1) EP0921806B1 (de)
JP (2) JP4971534B2 (de)
AT (1) ATE249225T1 (de)
AU (1) AU721224B2 (de)
CA (1) CA2261988C (de)
DE (1) DE69724798T2 (de)
DK (1) DK0921806T3 (de)
ES (1) ES2206737T3 (de)
GB (1) GB9616896D0 (de)
PT (1) PT921806E (de)
WO (1) WO1998006406A1 (de)
ZA (1) ZA977151B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616896D0 (en) * 1996-08-12 1996-09-25 British Tech Group Pharmaceutical compositions
WO2004031379A1 (en) * 2002-10-01 2004-04-15 Unilever N.V. Proteins having polysaccharidase activity
US9517023B2 (en) 2009-06-01 2016-12-13 Profusa, Inc. Method and system for directing a localized biological response to an implant
GB0910078D0 (en) * 2009-06-11 2009-07-22 Renovo Ltd Uses of mannose-6-phosphate
GB0916333D0 (en) 2009-09-17 2009-10-28 Renovo Ltd Improvement of tendon repair
US10010272B2 (en) 2010-05-27 2018-07-03 Profusa, Inc. Tissue-integrating electronic apparatus
KR101690535B1 (ko) 2010-10-06 2017-01-09 프로퓨사 인코퍼레이티드 조직-일체화 센서
AU2014241420B2 (en) 2013-03-14 2018-05-31 Profusa, Inc. Method and device for correcting optical signals
AU2014274784B2 (en) 2013-06-06 2018-12-06 Profusa, Inc. Apparatus and methods for detecting optical signals from implanted sensors
US11331018B2 (en) 2016-12-22 2022-05-17 Profusa, Inc. System and single-channel biosensor for and method of determining analyte value
GB201904469D0 (en) * 2019-03-29 2019-05-15 Givaudan Sa Cosmetic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244651A (en) * 1991-09-04 1993-09-14 Kao Corporation Method of desensitizing hypersensitive dentin
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB9616896D0 (en) * 1996-08-12 1996-09-25 British Tech Group Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0921806A1 (de) 1999-06-16
WO1998006406A1 (en) 1998-02-19
ZA977151B (en) 1999-02-11
EP0921806B1 (de) 2003-09-10
JP2000516603A (ja) 2000-12-12
AU3776997A (en) 1998-03-06
ATE249225T1 (de) 2003-09-15
DE69724798T2 (de) 2004-07-15
CA2261988C (en) 2006-11-07
GB9616896D0 (en) 1996-09-25
CA2261988A1 (en) 1998-02-19
ES2206737T3 (es) 2004-05-16
JP4971534B2 (ja) 2012-07-11
DE69724798D1 (de) 2003-10-16
PT921806E (pt) 2003-12-31
AU721224B2 (en) 2000-06-29
JP2009221220A (ja) 2009-10-01

Similar Documents

Publication Publication Date Title
DE69302823T2 (de) Kieselsäuresole, verfahren zur herstellung von kieselsäuresolen und verwendung von diesen solen
ATE207753T1 (de) Wundheilmittel
DE69929810D1 (de) Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
PA8447801A1 (es) Derivados del acido hexanoico
DE3580769D1 (de) Zusammensetzungen und verfahren zur wundheilung.
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
PT862452E (pt) Formulacao de estabilizacao para o ngf
MY133125A (en) Novel dihydroxyhexanoic acid derivatives
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
HK1031998A1 (en) Stable compositions comprising levosimendan and alginic acid
DE69633392D1 (de) Verwendung von betalycan zur verminderung der narbenbildung
YU42401A (sh) Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
DE69514912D1 (de) Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
MY102063A (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE3751059T2 (de) Verwendung von Corticosteroide zur Verringerung von postoperativen Schmerzen.